REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/24/2025
Back to search
Official data from USPTO
SIMCERE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
11/25/2025
Trademark type
Combined
Nice classes
5
Filing date
09/02/2019
Registration date
11/24/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/24/2020
Last transaction
11/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
CN
Examiner
VO, JULIE
Law office
N50
Current location
TMO LAW OFFICE 123
Mark description
The mark consists of a design of a running person composed of geometric figures, displayed within a flag-like rectangular design and the wording "SIMCERE" to the right.
Holders and representatives
Holders
Jiangsu Simcere Pharmaceutical Co., Ltd
Representatives
Dana Stewart-Mekdara Global Trademarks, Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicated troches; Medicines for the prevention and treatment of cancercentral nervous system diseasesautoimmune diseasescardiovascular diseasesgastrointestinal diseaseslung diseaseosteoporosisricketschondropathyrenal osteopathyhypoparathyroidismdental diseaseshyperlipidemiadepressionhypercholesteremiakidney diseasesmusclo-skeletal disordersinfectionsbacterial infectionsall for human purposes; Biochemicial * Biochemical * drug for the prevention and treatment of cancercentral nervous system diseasesautoimmune diseasescardiovascular diseasesgastrointestinal diseaseslung diseaseosteoporosisricketschondropathyrenal osteopathyhypoparathyroidismdental diseaseshyperlipidemiadepressionhypercholesteremiakidney diseasesmusculo-skeletal disordersinfectionsbacterial infectionsall for human purposes; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical purposes; Active pharmaceutical ingredientsextracts of hops for pharmaceutical purposeseucalyptus for pharmaceutical purposesmint for pharmaceutical purposesmalt for pharmaceutical purposespepsins for pharmaceutical purposesthymol for pharmaceutical purposesturpentine for pharmaceutical purposesflaxseed for pharmaceutical purposesferments for pharmaceutical purposescytostatics for pharmaceutical purposesbalms for pharmaceutical purposesdigestives for pharmaceutical purposesiodine for pharmaceutical purposesalcohol for pharmaceutical purposesstarch for pharmaceutical purposes; Pharmaceutical preparations for injection for the prevention and treatment of cancercentral nervous system diseasesautoimmune diseasescardiovascular diseasesgastrointestinal diseaseslung diseaseosteoporosisricketschondropathyrenal osteopathyhypoparathyroidismdental diseaseshyperlipidemiadepressionhypercholesteremiakidney diseasesmusclo-skeletal disordersinfectionsbacterial infectionsall for human purposes; Chinese patent medicines for the prevention and treatment of cancercentral nervous system diseasesautoimmune diseasescardiovascular diseasesgastrointestinal diseaseslung diseaseosteoporosisricketschondropathyrenal osteopathyhypoparathyroidismdental diseaseshyperlipidemiadepressionhypercholesteremiakidney diseasesandmusclo-skeletal disordersinfectionsbacterial infectionsall for human purposes
Publications
History of USPTO decisions and trademark events.
37 publications found
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
04/18/2024
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
04/08/2024
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
09/12/2023
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
08/16/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/08/2023
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
08/08/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
07/09/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/27/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/21/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/26/2021
FIMP
FINAL DISPOSITION PROCESSED
02/26/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/24/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
11/24/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/08/2020
PUBO
PUBLISHED FOR OPPOSITION
09/08/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/19/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/03/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
08/03/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/03/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
08/03/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/03/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/27/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/27/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/27/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/24/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/23/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/23/2020
RFNT
REFUSAL PROCESSED BY IB
03/13/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/22/2020
RFRR
REFUSAL PROCESSED BY MPU
02/22/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/28/2020
CNRT
NON-FINAL ACTION WRITTEN
01/27/2020
MAFR
APPLICATION FILING RECEIPT MAILED
01/21/2020
DOCK
ASSIGNED TO EXAMINER
01/17/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/17/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/16/2020
Continuous trademark protection
Get notified about every new filing that threatens SIMCERE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.